rosiglitazone has been researched along with Respiratory Syncytial Virus Infections in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blanco, JC; Feola, DJ; Finkelman, FD; Lai, W; Pletneva, LM; Shirey, KA; Vogel, SN | 1 |
1 other study(ies) available for rosiglitazone and Respiratory Syncytial Virus Infections
Article | Year |
---|---|
Agents that increase AAM differentiation blunt RSV-mediated lung pathology.
Topics: Animals; Antigen-Antibody Complex; Arachidonate 5-Lipoxygenase; Arginase; Azithromycin; Cell Differentiation; Drug Evaluation, Preclinical; Gene Expression Regulation; Interleukin-4; Lectins, C-Type; Lung; Macrophages; Mannose Receptor; Mannose-Binding Lectins; Mice; Mice, Inbred BALB C; PPAR gamma; Receptors, Cell Surface; Recombinant Proteins; Respiratory Syncytial Virus Infections; RNA, Messenger; Rosiglitazone; Sigmodontinae; Signal Transduction; STAT6 Transcription Factor; Thiazolidinediones | 2014 |